Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis

Published:2018-04 Issue:4 Volume:27 Page:988-997
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Liu Huihui,Zheng Huaguang,Cao Yongjun,Pan Yuesong,Wang David,Zhang Runhua,You Shoujiang,Zhang Xinmiao,Li Shuya,Tong Xu,Liu Chun-feng,Wang Yilong

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery

Reference26 articles.

1. Tissue plasminogen activator for acute ischemic stroke;N Engl J Med,1995

2. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan alteplase clinical trial (j-act);Yamaguchi;Stroke,2006

3. Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients;Chao;Stroke,2014

4. Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose;Chen;J Thromb Haemost,2012

5. Comparison of the efficacy and safety of the acute stroke patients receiving different dose intravenous tissue plasminogen activator;Liao;Stroke,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acil Serviste Trombolitik Uygulanan Hastaların Özellikleri;Genel Tıp Dergisi;2023-02-28

2. Effect of the interaction between atrial fibrillation and rt-PA dose on the prognosis of acute ischaemic stroke with intravenous thrombolysis;Postgraduate Medical Journal;2022-06-24

3. Determinants for a low dose of alteplase and its relationship to a lower intracerebral bleeding risk in acute ischemic stroke;International Journal of Medical Sciences;2022

4. Thrombolysis in Acute Stroke;Cerebrovascular Diseases [Working Title];2021-11-23

5. Pharmacodynamics and Pharmacokinetics of Stroke Therapy;Precision Medicine in Stroke;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3